Evidence map›Paper›PMID 35905286›Full record

ArticleScience immunology2022

Epithelial HVEM maintains intraepithelial T cell survival and contributes to host protection.

Goo-Young Seo, Daisuke Takahashi, Qingyang Wang, Zbigniew Mikulski, Angeline Chen, Ting-Fang Chou, Paola Marcovecchio, Sara McArdle, Ashu Sethi, Jr-Wen Shui and 4 more

Open access · greenAbstract read
In one paragraph

Article in Science immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. CD160Nature cell biology · 2025
    Article
  6. Article
  7. A novel HVEM-Fc recombinant protein for lung cancer immunotherapy.Journal of experimental & clinical cancer research : CR · 2025
    Article
  8. Article
  9. Review
  10. Review
  11. Frontiers in microbiology · 2025
    Review
  12. Article
  13. NADScience translational medicine · 2024
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 2 countries.

Goo-Young SeoLa Jolla Institute for Immunology, La Jolla, CA, USA.ORCID 0000-0001-5517-724X
Daisuke TakahashiLa Jolla Institute for Immunology, La Jolla, CA, USA.ORCID 0000-0001-8624-1160
Qingyang WangLa Jolla Institute for Immunology, La Jolla, CA, USA.ORCID 0000-0002-9999-3019
Zbigniew MikulskiLa Jolla Institute for Immunology, La Jolla, CA, USA.ORCID 0000-0002-1918-9216
Angeline ChenLa Jolla Institute for Immunology, La Jolla, CA, USA.ORCID 0000-0003-3619-0478
Ting-Fang ChouLa Jolla Institute for Immunology, La Jolla, CA, USA.ORCID 0000-0001-7095-3518
Paola MarcovecchioLa Jolla Institute for Immunology, La Jolla, CA, USA.
Sara McArdleLa Jolla Institute for Immunology, La Jolla, CA, USA.ORCID 0000-0003-3795-3772
Ashu SethiLa Jolla Institute for Immunology, La Jolla, CA, USA.
Jr-Wen ShuiLa Jolla Institute for Immunology, La Jolla, CA, USA.ORCID 0000-0002-5243-3727
Masumi TakahashiLa Jolla Institute for Immunology, La Jolla, CA, USA.
Charles D SurhLa Jolla Institute for Immunology, La Jolla, CA, USA.
Hilde CheroutreLa Jolla Institute for Immunology, La Jolla, CA, USA.ORCID 0000-0002-3669-2964
Mitchell KronenbergLa Jolla Institute for Immunology, La Jolla, CA, USA.ORCID 0000-0001-6318-6445
La Jolla Institute for Immunology · US

Funding

Using polygenic scores to enhance both variant discovery, and understanding of functional consequences of genetic variation in IBD.P01DK046763 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI TARGAN, STEPHAN R. · 1992 to 2020
$31.1M
The role of LIGHT in Colitis PathogenesisR01AI061516 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI KRONENBERG, MITCHELL · 2004 to 2015
$4.5M
Control of the Functional Fate of CD4 T Cells by LncRNA-SwitchU01AI125957 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CHEROUTRE, HILDE MC · 2016 to 2020
$2.7M
HVEM: A TNF family receptor that influences mucosal immunity and the microbiomeU01AI125955 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI KRONENBERG, MITCHELL · 2016 to 2020
$2.7M
Super-resolution confocal microscopeS10OD021831 · OD · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI LEY, KLAUS F. · 2017 to 2017
$566k
FACSAria II Cell SorterS10RR027366 · NCRR · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 2011 to 2011
$514k
NCRR NIH HHS S10 RR027366NIAID NIH HHS R01 AI061516NIAID NIH HHS U01 AI125955NIAID NIH HHS U01 AI125957NIDDK NIH HHS P01 DK046763NIH HHS S10 OD021831
6 · The paper itself

Abstract

Intraepithelial T cells (IETs) are in close contact with intestinal epithelial cells and the underlying basement membrane, and they detect invasive pathogens. How intestinal epithelial cells and basement membrane influence IET survival and function, at steady state or after infection, is unclear. The herpes virus entry mediator (HVEM), a member of the TNF receptor superfamily, is constitutively expressed by intestinal epithelial cells and is important for protection from pathogenic bacteria. Here, we showed that at steady-state LIGHT, an HVEM ligand, binding to epithelial HVEM promoted the survival of small intestine IETs. RNA-seq and addition of HVEM ligands to epithelial organoids indicated that HVEM increased epithelial synthesis of basement membrane proteins, including collagen IV, which bound to β

Indexed as

Intraepithelial LymphocytesAnimalsCollagenEpithelial CellsIntegrinsLigandsMiceCollagenIntegrinsLigands

Identifiers

PMID35905286
PMCPMC9422995
OpenAlexW4288695076

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.